Categories: All postsCannabis

Flower One Holdings has a 117 per cent upside, says Mackie Research

US cannabis company Flower One Holdings (Flower One Holdings Stock Quote, Chart CSE:FONE) just got a target raise from Mackie Research’s Greg McLeish, who, after touring facilities, says the company’s Nevada build-out is progressing smoothly.

Vertically-integrated cannabis company Flower One has now completed conversion of its commercial greenhouse in North Las Vegas, making it capable of producing more than 62,500 kg of dried flower per year, by far the largest cannabis cultivation operation in the state.

In a client update Thursday, McLeish says Nevada’s climate, with its 290 days of sunlight per year and more than ten hours of sunlight per day, plus its dry heat and low humidity, is ideal for growing cannabis in a greenhouse environment.

A dollar per gram for Flower One Holdings

The analyst says the scale of FONE’s operations should result in an all-in cash cost per gram of less than $1.00, which he says compares very favourably to competitors that operate smaller-scale greenhouses and indoor operations. Once Flower One reaches scale, McLeish says that it should be generating EBITDA margins above 30 per cent. (All figures in US dollars unless noted otherwise.)

“We had been applying a 10x EV/EBITDA multiple to value Flower One to take into account the execution risk associated with building out a successful large scale greenhouse operation. However, this execution risk has been mitigated as evidenced by our recent tour of the NLV Greenhouse. Additionally, the closing of the C$57.5 million convertible debenture financing and the recently announced licensing agreements and brand partnerships will help to underpin our financial forecasts through 2020. As a result, we are increasing our EV/EBITDA target multiple to 11x from 10x,” says McLeish.

The analyst is calling for fiscal 2019 revenue and EBITDA of $134.9 million and $45.1 million, respectively, and fiscal 2020 revenue and EBITDA of $251.1 million and $90.6 million, respectively. McLeish is maintaining his “Buy” rating and moving his target price from C$5.50 to C$6.50, which represented a projected return of 117 per cent at the time of publication.

Flower One Holdings Company Profile via Mackie Research Capital

Flower One Holdings Inc. is a vertically integrated cannabis company that is targeting the medical and recreational cannabis markets in the state of Nevada. The company is currently in the process of retrofitting its 455,000 ft² “NLV Greenhouse” into a cannabis cultivation and production facility. The conversion of the greenhouse is now complete and once the facility is fully operational, it will be capable of producing more than 140,000 pounds (62,500 kilograms) of dry flower per year.

Tagged with: fone
Jayson MacLean

Jayson is a writer, researcher and educator with a PhD in political philosophy from the University of Ottawa. His interests range from bioethics and innovations in the health sciences to governance, social justice and the history of ideas.

Recent Posts

Will AI kill Shopify?

National Bank Financial analyst Richard Tse said the impact of AI on tech valuations is becoming more company-specific, with names… [Read More]

3 hours ago

Meta is the best “Magnificent Seven” stock right now, this investor says

ScotiaMcLeod Newman Group advisor and portfolio manager Greg Newman told BNN Bloomberg’s Market Call on April 24 that Meta Platforms … [Read More]

22 hours ago

GLP-1 trade? McKesson is your stock, this investor says

Goodreid Investment Counsel president and CEO Gordon Reid told BNN Bloomberg’s Market Call on April 23 that McKesson (McKesson Stock… [Read More]

22 hours ago

Metatek-Group is a buy, this analyst says

Beacon Securities analyst Russell Stanley initiated coverage of Metatek-Group (Metatek-Group Stock Quote, Chart, News, Analysts, Financials TSX:MTEK) with a “Buy”… [Read More]

23 hours ago

This Canadian penny stock is undervalued, analyst says

Clarus Securities analyst Noel Atkinson said in an April 23 update that AmeriTrust Financial Technologies (AmeriTrust Financial Technologies Stock Quote,… [Read More]

1 day ago

Pot reclassification is not enough to move the needle, analyst says

Haywood analyst Neal Gilmer said the U.S. decision to immediately reclassify state-licensed medical marijuana from Schedule I to Schedule III… [Read More]

2 days ago